Vol 9, No 1 (February 28, 2020): Chinese Clinical Oncology (Biliary Tract Cancers)

Editorial

On the cusp of a sea change in biliary tract cancer

Milind Javle

PDF Pages: 1 Full Text (1205) Open Access

Review Article

Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)

Christopher D. Jakubowski, Nilofer S. Azad

PDF Pages: 2 Full Text (9072) Open Access

Modern gastrointestinal endoscopic techniques for biliary tract cancers

Osman Ahmed, Jeffrey H. Lee

PDF Pages: 3 Full Text (2587) Open Access

Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy

Michael K. Turgeon, Shishir K. Maithel

PDF Pages: 4 Full Text (4019) Open Access

Biliary tract cancers: systemic therapy for advanced disease

Francisco J. Martinez, Rachna T. Shroff

PDF Pages: 5 Full Text (3195) Open Access

Biliary tract cancer and genomic alterations in homologous recombinant deficiency: exploiting synthetic lethality with PARP inhibitors

Daniel H. Ahn, Tanios Bekaii-Saab

PDF Pages: 6 Full Text (4845) Open Access

Targets for therapy in biliary tract cancers: the new horizon of personalized medicine

Pritish Iyer, Ming-Huang Chen, Lipika Goyal, Crystal S. Denlinger

PDF Pages: 7 Full Text (3426) Open Access

Interventional radiology approaches for intra-hepatic cholangiocarcinoma

Cristina Mosconi, Marco Calandri, Milind Javle, Bruno C. Odisio

PDF Pages: 8 Full Text (4613) Open Access

Guideline

Guidelines for biliary stents and drains

Lorraine C. Drapek, Robert K. Kerlan Jr, Susan Acquisto

PDF Pages: 9 Full Text (9460) Open Access

Review Article

Radiation dose escalation for locally advanced unresectable intrahepatic and extrahepatic cholangiocarcinoma

Santiago Avila, Danyal A. Smani, Eugene J. Koay

PDF Pages: 10 Full Text (2338) Open Access

Disclosure:

The focused issue “Biliary Tract Cancers” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Milind Javle served as the unpaid Guest Editor for the focused issue.